Polycystic kidney disease

Annual Review of Medicine

Volumn 60, Issue , 2009, Pages 321-337

  Harris, Peter C ^a   Torres, Vicente E ^a  

^a MAYO CLINIC   (United States)

Author keywords

ADPKD; ARPKD; Fibrocystin; Polycystin 1; Polycystin 2

Indexed keywords

BETA CATENIN; EVEROLIMUS; FIBROCYSTIN; ICOSAPENTAENOIC ACID; LISINOPRIL; OCTREOTIDE; PLACEBO; POLYCYSTIN 1; POLYCYSTIN 2; PRAVASTATIN; RAPAMYCIN; SOMATOSTATIN; TELMISARTAN; TOLVAPTAN; VASOPRESSIN; WNT PROTEIN;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL RECESSIVE DISORDER; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; GENE MUTATION; HUMAN; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; POLYCYSTIC KIDNEY DISEASES;

EID: 67249091839     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.60.101707.125712     Document Type: Review

References (108)

1. Torres VE, Harris PC, Pirson Y. 2007. Autosomal dominant polycystic kidney disease. Lancet 369:1287-301
2. Rossetti S, Harris PC. 2007. Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease. J. Am. Soc. Nephrol. 18:1374-80
3. Harris PC, Torres VE. 2006. Autosomal dominant polycystic kidney disease. In GeneReviews; Genetic Diseases Online Reviews at Gene-Test-GeneClinics, Univ.Washington, Seattle. http://www.ncbi.nlm. nih.gov/bookshelf/br. fcgi?book=gene&part=pkd-ad
4. Grantham JJ, Torres VE, Chapman AB, et al. 2006. Volume progression in polycystic kidney disease. N. Engl. J. Med. 354:2122-30
5. European Polycystic Kidney Disease Consortium. 1994. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77:881-94
6. Hughes J, Ward CJ, Peral B, et al. 1995. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10:151-60
7. International Polycystic Kidney Disease Consortium. 1995. Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81:289-98
8. Mochizuki T, Wu G, Hayashi T, et al. 1996. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339-42
9. Rossetti S, Consugar MB, Chapman AB, et al. 2007. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 18:2143-60
10. Hateboer N, van Dijk MA, Bogdanova N, et al. 1999. Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353:103-7
11. Harris PC, Bae K, Rossetti S, et al. 2006. Cyst number but not the rate of cystic growth is associated with the mutated gene in ADPKD. J. Am. Soc. Nephrol. 17:3013-19
12. Davila S, Furu L, Gharavi AG, et al. 2004. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat. Genet. 36:575-77
13. Drenth JP, Te Morsche RH, Smink R, et al. 2003. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease. Nat. Genet. 33:345-47
14. Rossetti S, Burton S, Strmecki L, et al. 2002. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J. Am. Soc. Nephrol. 13:1230-37
15. Magistroni R, He N, Wang K, et al. 2003. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 14:1164-74
16. Rossetti S, Chauveau D, Kubly V, et al. 2003. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361:2196-201
17. Connor A, Lunt PW, Dolling C, et al. 2008. Mosaicism in autosomal dominant polycystic kidney disease revealed by genetic testing to enable living related renal transplantation. Am. J. Transplant. 8:232-37
18. Consugar MB, Wong WC, Lundquist PA, et al. 2008. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int. online doi:10-1078/Ki.2008.485
19. Lu W, Peissel B, Babakhanlou H, et al. 1997. Perinatal lethality with kidney and pancreas defects in mice with a targeted Pkd1 mutation. Nature Genet. 17:179-81
20. Lu W, Fan X, Basora N, et al. 1999. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nature Genet. 21:160-61
21. Lantinga-van Leeuwen IS, Leonhard WN, Van Der Wal A, et al. 2007. Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum. Mol. Genet. 16:3188-96
22. Piontek K, Menezes LF, Garcia-Gonzalez MA, et al. 2007. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat. Med. 13:1490-95
23. Pei Y,Watnick T, He N, et al. 1999. Somatic PKD2 mutations in individual kidney and liver cysts support a two-hit model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 10:1524-29
24. Qian F, Watnick TJ, Onuchic LF, et al. 1996. The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 87:979-87
25. Wu G, D'Agati V, Cai Y, et al. 1998. Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell 93:177-88
26. Lantinga-van Leeuwen IS, Dauwerse JG, Baelde HJ, et al. 2004. Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. Hum. Mol. Genet. 13:3069-77
27. Ponting CP, Hofmann K, Bork P. 1999. A latrophilin/CL-1-like GPS domain in polycystin-1. Curr. Biol. 9: R585-88
28. Sandford R, Sgotto B, Aparacio S, et al. 1997. Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum. Mol. Genet. 6:1483-89
29. 2+-permeable nonselective cation channel. Proc. Natl. Acad. Sci. USA 98:1182-87
30. Koulen P, Cai Y, Geng L, et al. 2002. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 4:191-97
31. Qian F, Boletta A, Bhunia AK, et al. 2002. Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc. Natl. Acad. Sci. USA 99:16981-86
32. Yu S, Hackmann K, Gao J, et al. 2007. Essential role of cleavage of polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure. Proc. Natl. Acad. Sci. USA 104:18688-93
33. Chauvet V, Tian X, Husson H, et al. 2004. Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus. J. Clin. Invest. 114:1433-43
34. Low SH, Vasanth S, Larson CH, et al. 2006. Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease. Dev. Cell 10:57-69
35. Li X, Luo Y, Starremans PG, et al. 2005. Polycystin-1 and polycystin-2 regulate the cell cycle through the helix-loop-helix inhibitor Id2. Nat. Cell Biol. 7:1102-12
36. Pazour GJ, San Agustin JT, Follit JA, et al. 2002. Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease. Curr. Biol. 12:R378-80
37. Yoder BK, Hou X, Guay-Woodford LM. 2002. The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are colocalized in renal cilia. J. Am. Soc. Nephrol. 13:2508-16
38. Lin F, Hiesberger T, Cordes K, et al. 2003. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc. Natl. Acad. Sci. USA 100:5286-91
39. Nauli SM, Alenghat FJ, Luo Y, et al. 2003. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 33:129-37
40. Praetorius HA, Spring KR. 2001. Bending theMDCKcell primary cilium increases intracellular calcium. J. Membr. Biol. 184:71-79
41. Pisitkun T, Shen RF, Knepper MA. 2004. Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 101:13368-73
42. Hogan MC,Manganelli L,Woollard JR, et al. 2008. Characterization of polycystic kidney disease protein (PKD) positive exosome-like vesicles. J. Am. Soc. Nephrol. In press
43. Tanaka Y, Okada Y, Hirokawa N. 2005. FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left-right determination. Nature 435:172-77
44. McGrath J, Somlo S, Makova S, et al. 2003. Two populations of node monocilia initiate left-right asymmetry in the mouse. Cell 114:61-73
45. Pennekamp P, Karcher C, Fischer A, et al. 2002. The ion channel polycystin-2 is required for left-right axis determination in mice. Curr. Biol. 12:938-43
46. Ong AC, Harris PC. 2005. Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney Int. 67:1234-47
47. Sutton KA, Jungnickel MK, Florman HM. 2008. A polycystin-1 controls postcopulatory reproductive selection in mice. Proc. Natl. Acad. Sci. USA 105:8661-66
48. Ishimaru Y, Inada H, Kubota M, et al. 2006. Transient receptor potential family members PKD1L3 and PKD2L1 form a candidate sour taste receptor. Proc. Natl. Acad. Sci. USA 103:12569-74
49. Huang AL, Chen X, Hoon MA, et al. 2006. The cells and logic for mammalian sour taste detection. Nature 442:934-38
50. Yamaguchi T, Hempson SJ, Reif GA, et al. 2006. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J. Am. Soc. Nephrol. 17:178-87
51. Gattone VH 2nd, Wang X, Harris PC, et al. 2003. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat. Med. 9:1323-26
52. Torres VE, Wang X, Qian Q, et al. 2004. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nature Med. 10:363-64
53. Yamaguchi T, Nagao S, Kasahara M, et al. 1997. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am. J. Kidney Dis. 30:703-9
54. Yamaguchi T, Nagao S,Wallace DP, et al. 2003. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int. 63:1983-94
55. Yamaguchi T, Pelling JC, Ramaswamy NT, et al. 2000. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int. 57:1460-71
56. Yamaguchi T, Wallace DP, Magenheimer BS, et al. 2004. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J. Biol. Chem. 279:40419-30
57. Sampson JR, Maheshwar MM, Aspinwall R, et al. 1997. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am. J. Hum. Genet. 61:843-51
58. Shillingford JM, Murcia NS, Larson CH, et al. 2006. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl. Acad. Sci. USA 103:5466-71
59. Masyuk TV, Masyuk AI, Torres VE, et al. 2007. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′,5′-cyclic monophosphate. Gastroenterology 132:1104-16
60. Ruggenenti P, Remuzzi A, Ondei P, et al. 2005. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Kidney Int. 68:206-16
61. Qian Q, Du H, King BF, et al. 2008. Sirolimus reduces polycystic liver volume in ADPKD patients. J. Am. Soc. Nephrol. 19:631-38
62. Yang B, Sonawane ND, Zhao D, et al. 2008. Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 19:1300-10
63. Albaqumi M, Srivastava S, Li Z, et al. 2008. KCa3.1 potassium channels are critical for cAMP-dependent chloride secretion and cyst growth in autosomal-dominant polycystic kidney disease. Kidney Int. 74:740-49
64. Alper SL. 2008. Let's look at cysts from both sides now. Kidney Int.74:699-702
65. Leuenroth SJ, Okuhara D, Shotwell JD, et al. 2007. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc. Natl. Acad. Sci. USA 104:4389-94
66. Leuenroth SJ, Bencivenga N, Igarashi P, et al. 2008. Triptolide reduces cystogenesis in a model of ADPKD. J. Am. Soc. Nephrol. 19:1659-62
67. Sweeney WE Jr, von Vigier RO, Frost P, et al. 2008. Src inhibition ameliorates polycystic kidney disease. J. Am. Soc. Nephrol. 19:1331-41
68. Wilson SJ, Amsler K, Hyink DP, et al. 2006. Inhibition of HER-2(neu/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia. Biochim. Biophys. Acta 1762:647-55
69. Sweeney WE Jr, Hamahira K, Sweeney J, et al. 2003. Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. Kidney Int. 64:1310-19
70. Tao Y, Kim J, Yin Y, et al. 2007. VEGF receptor inhibition slows the progression of polycystic kidney disease. Kidney Int. 72:1358-66
71. Li X, Magenheimer BS, Xia S, et al. 2008. A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat. Med. 14:863-68
72. Park F, Sweeney WE, Jia G, et al. 2008. 20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease. J. Am. Soc. Nephrol. 19(10):1929-39
73. Higashihara E, Nutahara K, Horie S, et al. 2002. The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD. Nephrol. Dial. Transplant. 23:2847-52
74. Bukanov NO, Smith LA, Klinger KW, et al. 2006. Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine. Nature 444:949-52
75. Guay-Woodford LM, Desmond RA. 2003. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 111:1072-80
76. Adeva M, El-Youssef M, Rossetti S, et al. 2006. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ADPKD). Medicine 85:1-21
77. Onuchic LF, Furu L, Nagasawa Y, et al. 2002. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am. J. Hum. Genet. 70:1305-17
78. Ward CJ, Hogan MC, Rossetti S, et al. 2002. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 30:259-69
79. Bergmann C, Senderek J, Sedlacek B, et al. 2003. Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J. Am. Soc. Nephrol. 14:76-89
80. Moser M, Matthiesen S, Kirfel J, et al. 2005. A mouse model for cystic biliary dysgenesis in autosomal recessive polycystic kidney disease (ARPKD). Hepatology 41:1113-21
81. Woollard JR, Punyashtiti R, Richardson S, et al. 2007. A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation. Kidney Int. 72:328-36
82. Mai W, Chen D, Ding T, et al. 2005. Inhibition of Pkhd1 impairs tubulomorphogenesis of cultured IMCD cells. Mol. Biol. Cell 16:4398-409
83. Masyuk TV, Huang BQ,Ward CJ, et al. 2003. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology 125:1303-10
84. Kim I, Fu Y, Hui K, et al. 2008. Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. J. Am. Soc. Nephrol. 19:455-68
85. Wang S, Zhang J, Nauli SM, et al. 2007. Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol. Cell Biol. 27:3241-52
86. Ward CJ, Yuan D, Masyuk TV, et al. 2003. Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Hum. Mol. Genet. 12:2703-10
87. Wu Y, Dai XQ, Li Q, et al. 2006. Kinesin-2 mediates physical and functional interactions between polycystin-2 and fibrocystin. Hum. Mol. Genet. 15:3280-92
88. Kaimori JY, Nagasawa Y, Menezes LF, et al. 2007. Polyductin undergoes notch-like processing and regulated release from primary cilia. Hum. Mol. Genet. 16:942-56
89. 2+ and activation of protein kinase C. J. Biol. Chem. 281:34357-64
90. Hogan MC, Griffin MD, Rossetti S, et al. 2003. PKHDL1, a homolog of the autosomal recessive polycystic kidney disease gene, encodes a receptor with inducible T lymphocyte expression. Hum. Mol. Genet. 12:685-89
91. Fliegauf M, Benzing T, Omran H. 2007. When cilia go bad: cilia defects and ciliopathies. Nat. Rev.Mol. Cell Biol. 8:880-93
92. Hildebrandt F, Zhou W. 2007. Nephronophthisis-associated ciliopathies. J. Am. Soc. Nephrol. 18:1855-71
93. Harris PC. 2007. Genetic complexity in Joubert syndrome and related disorders. Kidney Int. 72:1421-23
94. Beales PL. 2005. Lifting the lid on Pandora's box: the Bardet-Biedl syndrome. Curr. Opin. Genet. Dev. 15:315-23
95. Ferrante MI, Giorgio G, Feather SA, et al. 2001. Identification of the gene for oral-facial-digital type I syndrome. Am. J. Hum. Genet. 68:569-76
96. Badano JL, Kim JC, Hoskins BE, et al. 2003. Heterozygous mutations in BBS1, BBS2 and BBS6 have a potential epistatic effect on Bardet-Biedl patients with two mutations at a second BBS locus. Hum. Mol. Genet. 12:1651-59
97. Hoefele J, Wolf MT, O'Toole JF, et al. 2007. Evidence of oligogenic inheritance in nephronophthisis. J. Am. Soc. Nephrol. 18:2789-95
98. Leitch CC, Zaghloul NA, Davis EE, et al. 2008. Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome. Nat. Genet. 40:443-48
99. Arts HH, Doherty D, van Beersum SE, et al. 2007. Mutations in the gene encoding the basal body protein RPGRIP1L, a nephrocystin-4 interactor, cause Joubert syndrome. Nat. Genet. 39:882-88
100. Huangfu D, Liu A, Rakeman AS, et al. 2003. Hedgehog signalling in the mouse requires intraflagellar transport proteins. Nature 426:83-87
101. Haycraft CJ, Banizs B,Aydin-Son Y, et al. 2005. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet. 1:e53
102. Attanasio M, Uhlenhaut NH, Sousa VH, et al. 2007. Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis. Nat. Genet. 39:1018-24
103. Ross AJ, May-Simera H, Eichers ER, et al. 2005. Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates. Nat. Genet. 37:1135-40
104. Simons M, Gloy J, Ganner A, et al. 2005. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat. Genet. 37:537-43
105. Fischer E, Legue E, Doyen A, et al. 2006. Defective planar cell polarity in polycystic kidney disease. Nat. Genet. 38:21-23
106. The PKD Foundation: http://www.pkdcure.org/
107. The ARPKD Mutation Database: http://www.humgen.rwth-aachen.de/index. asp?subform= database.html&nav=database nav.html
108. The ADPKD Mutation Database: http://pkdb.mayo.edu/